8th Annual Proteins & Antibodies Congress 2015

Over 350 attendees working within Proteins, Antibodies and Biotherapeutics

Over 40 case studies, presentations and panel discussions focused on the key issues in protein expression, purification challenges and therapeutic antibodies. Co-Located with our 3rd Annual Biosimilars & Biobetters Congress and 2nd Annual Peptides Congress

4 interactive streams:
•    Protein Purification and Downstream Processing
•    Antibody Discovery and Engineering
•    Protein Expression and Characterisation
•    Therapeutic Antibodies and Alternative Scaffolds

14 pre-scheduled one to one meetings, exhibition and informal networking opportunities

Oxford Global Conferences are proud to present the 8th Annual Proteins & Antibodies Congress, taking place on 20-21 April 2015.

Our Annual Proteins Congress is Europe’s leading Congress on proteins and antibodies, bringing together over 350 senior-level decision makers working at the forefront of research into protein expression, purification and antibody therapeutics in Europe and the US. The Conference programme consists of world-class keynote addresses, industry and academic led presentations and panel debates, creating an executive platform for high-level scientific discussion for experts working in protein and antibody expression.

Our panel of protein science experts will discuss how to overcome purification bottlenecks, including membrane proteins and incorrectly folded proteins, and will also address some of the opportunities for optimizing purification processes with innovative continuous and integrated processing approaches. On Day Two the focus shifts to protein expression and characterisation challenges; our panel of speakers will offer case studies about engineering CHO cells for optimized protein expression, biophysical characterisation challenges and novel technologies for characterisation such as protein labelling and HDX Mass Spectrometry.

Over the two days we also have a panel of antibody experts who will discuss the latest antibody engineering and therapeutic applications research. Day One focuses on the discovery and engineering of next generation antibodies and will host world-class speakers sharing case studies about novel antibody drug conjugates, antibody library design and cellular display platforms. Day Two will feature high-level discussions about the therapeutic applications of engineered antibodies, including exciting research into antibodies to target ion channels, the application of T cell receptors in cancer therapies, emerging armed antibodies therapeutics and alternative scaffolds.

    2nd Annual Peptides Congress, 20-21 April 2015, London, UK

    3rd Annual Biosimilars & Biobetters Congress, 20-21 April 2015, London, UK

      Proteins & Antibodies, Peptides and Biosimilars & Biobetters 2015 Sponsors:

      Proteins & Antibodies, Peptides and Biosimilars & Biobetters 2014 Sponsors:

      • Engineered Antibodies


      Media Partners